Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164177 · ClinicalTrials.gov registry record · Phase 4
Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.
A Phase 4 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00164177 is a Phase 4 study that has completed, run by Braintree Laboratories. The registered enrollment target is 20 participants.
The verdict
NCT00164177, a Phase 4 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
To evaluate the efficacy of standard HalfLYTELY® as a bowel cleansing preparation for adult patients undergoing virtual colonoscopy (VC).
Interventions
- DRUG HalfLytely
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00164177
The ClinicalTrials.gov registry entry for NCT00164177 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HalfLytely is the first listed.
NCT00164177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00164177 about?
NCT00164177 is a clinical study titled "Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.". To evaluate the efficacy of standard HalfLYTELY® as a bowel cleansing preparation for adult patients undergoing virtual colonoscopy (VC).
What is the current status of trial NCT00164177?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2004-10.
What interventions are being tested in trial NCT00164177?
The interventions under investigation include: HalfLytely (DRUG).
Who is sponsoring clinical trial NCT00164177?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.